Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

The MHRA has approved aumolertinib for adult patients with non-small cell lung cancer (NSCLC), following a groundbreaking ...

NHS England has announced the roll-out of a new liquid biopsy blood test to help lung cancer patients receive targeted ...

There are currently 18.6 million cancer survivors living in the US, according to the American Cancer Society, and this number ...

Researchers from the Francis Crick Institute, UCL, Gustave Roussy and Memorial Sloan Kettering Cancer Center (MSK), have ...

Amgen's Imdelltra reduced the risk of death by 40% compared to chemotherapy for small cell lung cancer patients whose disease ...

The pharmaceutical company said late-stage trials showed that Tecentriq combined with lurbinectedin led to a 46% reduction in the risk of the disease progressing or death.

Whether you've just found out your non-small-cell lung cancer (NSCLC) has advanced, or you're already in treatment, learn how to make the most of your doctor appointment. FDA OKs New Treatment for ...

Pharmacokinetic analysis showed that the CSF to free plasma osimertinib ratio was 22%. Most safety profiles were grade 1 and 2. Treatment with 80 mg once daily osimertinib achieved a median OS of 15.0 ...